Crossover, double-blind clinical trial comparing almotriptan and ergotamine plus caffeine for acute migraine therapy.
European journal of neurology2007Láinez MJ, Galván J, Heras J, et al.
抄録
cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。
MeSH
Acute DiseaseAdultCaffeineCross-Over StudiesDouble-Blind MethodDrug Therapy, CombinationErgotamineFemaleHumansMaleMigraine DisordersNauseaPatient SatisfactionPhosphodiesterase InhibitorsPhotophobiaSerotonin Receptor AgonistsTreatment OutcomeTryptaminesVasoconstrictor Agents
DOI 10.1111/j.1468-1331.2006.01594.x
PMID 17355546
原文・出典を見る →